A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
about
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensIdentification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.
P2860
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
description
article
@en
im Februar 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2000
@uk
name
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@en
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@nl
type
label
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@en
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@nl
prefLabel
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@en
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
@nl
P2093
P1433
P1476
A phase I/II trial of HIV SF2 ...... Institute for Health Sciences
@en
P2093
A M Duliege
C Chuenchitra
C Khamboonruang
J G McNeil
J R Mascola
K Rungruengthanakit
L E Markowitz
P304
P356
10.1016/S0264-410X(99)00421-1
P407
P577
2000-02-01T00:00:00Z